Arylia 60 mg in pre-filled syringe

Denosumab 60 mg

Therapeutic Indications:

• treatment of postmenopausal osteoporosis in women and also men who have an increased risk of bone fractures
• Bone loss that results from a reduction in hormone (testosterone) level caused by surgery or treatment with medicines in patients with prostate cancer
• Treatment of bone loss associated with long-term systemic glucocorticoid therapy in adult patients at increased risk of fracture